Skip to main content
Publish date:

Alkermes To Take Part In The Citi Annual BioPharma Virtual Conference

DUBLIN, Sept. 2, 2021 /PRNewswire/ --  Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Citi 16 th Annual BioPharma Virtual Conference on Thursday, Sept.

DUBLIN, Sept. 2, 2021 /PRNewswire/ --  Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Citi 16 th Annual BioPharma Virtual Conference on Thursday, Sept. 9, 2021 at 8:50 a.m. ET ( 1:50 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at  www.alkermes.com

Contact: Alex BraunInvestor Relations+1 781 296 8493

View original content to download multimedia: https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-citi-annual-biopharma-virtual-conference-301368052.html

SOURCE Alkermes plc